Anuh Pharma Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Anuh Pharma Ltd is ₹ 81.99 as of 30 Apr 15:30 . The P/E Ratio of Anuh Pharma Ltd is 0 as of March 2025 .The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 . The Market Cap of Anuh Pharma Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 . The Revenue of Anuh Pharma Ltd is ₹ 0 crore as of Mar '25 .The Revenue of Remedium Lifecare Ltd is ₹ 264.98 crore as of Mar '25 . The EBITDA of Anuh Pharma Ltd is ₹ 0 crore as of Mar '25 .The EBITDA of Remedium Lifecare Ltd is ₹ 0.2 crore as of Mar '25 . The Net Profit of Anuh Pharma Ltd is ₹ 0 crore as of Mar '25 .The Net Profit of Remedium Lifecare Ltd is ₹ -2.05 crore as of Mar '25 . The Dividend Payout of Anuh Pharma Ltd changed from 26.43 % on March 2021 to 15.88 % on March 2025 . This represents a CAGR of -9.69% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anuh Pharma Ltd

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs).
The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals.
The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals.
It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960.
The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Anuh Pharma Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Anuh Pharma Ltd or Remedium Lifecare Ltd?

Market cap of Anuh Pharma Ltd is 821 Cr while Market cap of Remedium Lifecare Ltd is 40 Cr

What are the key factors driving the stock performance of Anuh Pharma Ltd and Remedium Lifecare Ltd?

The stock performance of Anuh Pharma Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anuh Pharma Ltd and Remedium Lifecare Ltd?

As of May 3, 2026, the Anuh Pharma Ltd stock price is INR ₹81.99. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.46.

How do dividend payouts of Anuh Pharma Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Anuh Pharma Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.